In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Instituto Nacional de Salud
2004
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866811890756222976 |
|---|---|
| author | Amelia Bernardelli |
| author_facet | Amelia Bernardelli |
| contents | In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs Amelia Bernardelli Nora Morcillo Julio Loureiro Viviana Quse Silvana Davenport Medicina seals tuberculosis in vitro susceptibility testing Mycobacteria strains belonging to the Mycobacterium tuberculosis complex were isolated fromseals found in the South Atlantic. The animals were received in Mundo Marino installations andtreated for Mycobacterium tuberculosis complex by conventional therapy of intensive care andenriched food supply; however, in all cases treatment failed. Necropsies of all animals revealedextensive lesions compatible with tuberculosis involving lungs, liver, spleen and lymphaticnodes. Classical biochemical methods as well as molecular techniques using the IS 6110 probeswere performed for mycobacterial identification. Furthermore, the LCx M. tuberculosis assay(Abbott Laboratories) identified all strains as Mycobacterium tuberculosis complex members.The in vitro susceptibility pattern was examined in mycobacterial strains isolated from sevenseals and in 3 reference strains - BCG, H37Rv ( M. tuberculosis) and AN5 ( Mycobacteriumbovis) - to 4 medications - isoniazid, rifampin, streptomycin and ethambutol. Minimal inhibitorydrug concentrations were determined by the Mycobacterial Growth Indicator Tube (BD Argentina)method and a microdilution and colorimetric assay using 3-(4-5 dimethyltiazol-2)-2,5diphenyltetrazolium bromide. All the isolates and the reference strains BCG and AN5 wereinhibited by MIC values similar to those of H37Rv with good agreement obtained by bothtechniques. These findings suggest that a therapeutic regimen aimed to seals diagnosed withtuberculosis play an important role in the prevention of tuberculosis transmission from infectedanimals to humans that are in routine contact with them 2004 artículo científico 0120-4157 https://www.redalyc.org/articulo.oa?id=84309813 en http://www.redalyc.org/revista.oa?id=843 Biomédica application/pdf Instituto Nacional de Salud Biomédica (Colombia) Num.Su1 Vol.24 |
| format | Artículo científico |
| id | redalyc_84309813 |
| language | en |
| publishDate | 2004 |
| publisher | Instituto Nacional de Salud |
| spellingShingle | In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs Amelia Bernardelli Medicina seals tuberculosis in vitro susceptibility testing In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs Amelia Bernardelli Nora Morcillo Julio Loureiro Viviana Quse Silvana Davenport Medicina seals tuberculosis in vitro susceptibility testing Mycobacteria strains belonging to the Mycobacterium tuberculosis complex were isolated fromseals found in the South Atlantic. The animals were received in Mundo Marino installations andtreated for Mycobacterium tuberculosis complex by conventional therapy of intensive care andenriched food supply; however, in all cases treatment failed. Necropsies of all animals revealedextensive lesions compatible with tuberculosis involving lungs, liver, spleen and lymphaticnodes. Classical biochemical methods as well as molecular techniques using the IS 6110 probeswere performed for mycobacterial identification. Furthermore, the LCx M. tuberculosis assay(Abbott Laboratories) identified all strains as Mycobacterium tuberculosis complex members.The in vitro susceptibility pattern was examined in mycobacterial strains isolated from sevenseals and in 3 reference strains - BCG, H37Rv ( M. tuberculosis) and AN5 ( Mycobacteriumbovis) - to 4 medications - isoniazid, rifampin, streptomycin and ethambutol. Minimal inhibitorydrug concentrations were determined by the Mycobacterial Growth Indicator Tube (BD Argentina)method and a microdilution and colorimetric assay using 3-(4-5 dimethyltiazol-2)-2,5diphenyltetrazolium bromide. All the isolates and the reference strains BCG and AN5 wereinhibited by MIC values similar to those of H37Rv with good agreement obtained by bothtechniques. These findings suggest that a therapeutic regimen aimed to seals diagnosed withtuberculosis play an important role in the prevention of tuberculosis transmission from infectedanimals to humans that are in routine contact with them 2004 artículo científico 0120-4157 https://www.redalyc.org/articulo.oa?id=84309813 en http://www.redalyc.org/revista.oa?id=843 Biomédica application/pdf Instituto Nacional de Salud Biomédica (Colombia) Num.Su1 Vol.24 |
| title | In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs |
| topic | Medicina seals tuberculosis in vitro susceptibility testing |
| url | https://www.redalyc.org/articulo.oa?id=84309813 |